## **The Network for Improving Critical-care Systems & Training (NICST)**
## **Report and Financial Statements Year ended: MARCH 2022**
## **Charity no: 1171106**
The trustees present their annual report and financial statements of the charity for the year ended 31st March 2022. The financial statements have been prepared in accordance with the accounting policies set out in The Charity Commission’s Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the ‘Financial Reporting Standard’ applicable in the UK and Republic of Ireland published on 16 July 2014, the Charities Act 2011, and comply with the NICST’s founding constitution.
The annual report addresses matters in the same order as the Charities SORP (FRS 102). The charity is registered in England and Wales and so reference is made to the Charity Commission’s public benefit guidance in shaping the Trust’s _aims and objectives_ . The section on _achievements and performance_ is framed from a public benefit viewpoint and reviews each activity in turn. Under the heading _monitoring achievement_ , it includes performance information (presented in tabular form) illustrating the achievements. A review of finances for the period reported is included in this report. This section has been compiled with the assistance of Hines Harvey Woods Limited Co. Reg. No. 4942170. The section on _plans for the future_ distinguishes between the broader strategic vision and specific plans for the following financial year. The _structure, governance and management_ section includes how trustees are selected, volunteers are supported and how decisions are made. A statement of trustees’ responsibilities in relation to the financial statements has also been included in accordance with FRC audit standards (ISA 700). This statement (see appendix 4 to Audit Practice Note 11, March 2012) is not a requirement of the Charities SORP (FRS 102).
## **Administrative details**
Charity name Network for Improving Critical-Care Systems and Training
1
|||
|---|---|
|Other name the charity uses|NICST|
|Registered charity number|1171106|
|Charity’s principal address|27 Rosemary Road
Blofield
Norwich
NR13 4QQ|
|Management and governance|A Beane (first trustee and chair) is responsible for day to day
management of the charity.
Expertise and advice regarding charitable law and constitution of
the CIO is sought from
Mr Philip Norton,_of_
Hansells Solicitors and FInancial Advisors.
13 The Close
Norwich
Norfolk
NR1 4DS
T 01603 615 731
F 01603 633 585
Email:info@hansells.co.uk|
|Financial report|The charities financial report was compiled and independently
reviewed by
Hines Harvey Woods Limited
Queens Head House
The Street
Acle
Norwich
NR13 3DY
Co. Reg. No. 4942170
Tel: 01493 750207
Fax: 01493 750475
Email:mail@h-h-w.co.uk
Website: www.h-h-w.co.uk|
The Trustees’ Annual Report
2
## **1.0 Objectives and activities for the public benefit**
The purpose of the charity is the advancement of health for public benefit by improving the availability, delivery and quality of acute medical care through the development of clinical training for healthcare professionals, clinical teams and healthcare services. The charity has a particular (but not exclusive) focus in Low and Middle Income Countries (LMIC) by promoting translational research and collaborative working amongst healthcare teams. The trustees confirm that they have referred to the Charity Commission’s Guidance on public benefit when reviewing the charity’s aims and objectives and in planning future activities.
The charity furthers its charitable purposes for the public benefit through its five core objectives:
1. Creating and optimising a critical and acute care surveillance platform in Sri Lanka ( Nat- Intensive Care Surveillance, NICS-MORU) by providing academic and strategic leadership, and financial support to this subsidiary co-operative.
2. Establishing and developing data platforms to enable better patient care by using the NICST and NICS-MORU model of supporting health informatics projects in lower resourced healthcare settings.
3. Providing training for healthcare professionals, community and the general public in LMIC with an emphasis on skills and simulation based training.
4. Developing and implementing quality improvement interventions aimed at delivering better care for sick patients.
5. Promoting translational research and collaboration amongst healthcare teams.
By focussing on these areas NICST achieves the strategic priorities of improving access to good quality and highly practical acute and critical care skills training for health professionals and the public (‘training’) and developing informatics systems that can enable healthcare professionals to use data to better understand and ultimately improve health care systems. Facilitating research and enabling quality improvement support these priorities. Better training and better healthcare delivery systems lead to better patient care, providing public benefit.
The charity achieves these objectives predominantly through a partnership with NICS-MORU. NICS-MORU is Not-for-Profit Organisation (NPO) registered in Sri Lanka, aiming to improve acute and critical healthcare through the development, maintenance and improvement of systems enabling routine surveillance of care. The NPO, based in Sri Lanka, established in 2015 was pivotal in the development of one of the first national critical care registries in a LMIC, and remains at the forefront of developing and implementing systems to enable evaluation and improvement of acute care services in Asia and Africa. NICS-MORU has the expertise to be able to support NICST in meeting its charitable objectives. NICST and NICS-MORU share common objectives of capacity building and health system strengthening. A Checklist 3: Charities in a regular partnering or funding relationship with a non-charity that is not its founder or subsidiary document has been completed (2022) and will be updated annually. This checklist details the relationships and common objectives of the partnership. NICS-MORU employs LMIC based healthcare workers and scientists, providing employment and opportunity for setting based research in the region. NICS-MORU employs a local team of 16 FTE researchers, data collectors, web application developers and clinical tutors. NICS-MORU activities are non profit making with all charitable donations to the organisation going directly towards achieving the above objectives. Of note, Rashan Haniffa, first trustee of NICST is a director of NICS-MORU. His role in both organisations is voluntary, and the activities of both organisations does not provide him with any financial remuneration. All Charity trustees have completed a conflict of interest form.
3
## **2.0 Achievements and performance: how our objectives delivered public benefit.**
The benefits of NICST’s work are the mentorship, training of health care workers and future researchers, the development of new and strengthening of existing infrastructure for data driven research (observational and interventional) and the funding of on-going research to aid care of patients including those with critical illness and non communicable diseases. The trustees are pleased that the activities, impact, learning and achievements of the charity, as set out below, reflect these goals.
The NICST/NICS-MORU critical and acute care surveillance platform (first piloted and implemented nationally in Sri Lanka) has been adapted, optimised and scaled internationally to 17 countries in Asia and Africa. The surveillance platform;a central tenet of the 3 year nine country Wellcome- Oxford, “CRIT Care Asia”award funded from 2020-2022, remains central to the newly awarded Wellcome Award “CRIT Care Asia- Africa” funded from 2023-2025, of which NICS- MORU is the project implementation and data coordinating centre. Key deliverables of this new project are; registry sustainability, adaptation of the registry to enable data driven platform trials, capacity building for quality improvement and facilitation of international research to improve outcomes for critically ill patients, including through pandemic surveillance, multi morbidity management and improved patient experience NICST and NICS-MORU will provide expertise in implementation, data coordination, curation and analysis of data for research, clinical trials and quality improvement. As such the objectives of the charity will align with the deliverables for the Wellcome funded project and will be a leading priority for the charity for 2022-2025. The surveillance platform provides a mechanism for continuous evaluation of quality in healthcare across multiple countries.. Data captured through the platform is enabling patients and healthcare providers to engage in high quality international observational and interventional research. More about this collaboration and its published research output is described in **appendix 1** . Data derived from registry output is enhancing knowledge in response to the global COVID 19 pandemic, and within the wider global health and quality improvement community.
NICST has supported the initiation and expansion of registries in Asia-Africa, where there was little to no mechanism to provide systematic routine evaluation of the quality of critical care and no comprehensive information on critical care infrastructure. The information measured through the platform is directly accessible to the frontline clinician team with the aim of improving individual patient care. The aggregate information captured through the platform is enabling evaluation of processes and quality of care for patients who are critically and acutely unwell, for example, infection rates, delays in recovery, and mortality following hospital discharge.
Continuing the successful work delivered in 2020-21, in 2021-22-25the platform continues to be developed to support registry enabled clinical research (including trials) led by LMIC researchers. . NICST/ NICS-MORU have grown to be the data coordinating centre for international clinical trials; REMAP- CAP and Mega-ROX. NICST and NICS-MORU further play a central role in trial coordination, monitoring, patient safety, and data management prior to analysis. Within this role NICST/ NICS MORU has supported research naive healthcare communities in Asia to implement clinical trials, together seeking solutions to known barriers to clinical trials, including ethical, regulatory and resource barriers. To date NICST/ NICS-MORU has enabled the recruitment of 1800+ patients to clinical trials.
Commenced in 2021, but a priority for 2022 onwards, NICST and NICS MORU are partnering on LMIC investigator-led clinical trials focused on improving respiratory management in Africa; Uganda (ARISE trial) and Malawi, Kenya and Rwanda (Before BREATHE ).
4
New for 2021 onwards, NICST and NICS MORU successfully partnered with University of British Columbia, on a Canadian Institute Health Research grant to embed antimicrobial surveillance into the registry platform. In 2022-25, as part of its objective to build research capacity, NICST and NICS MORU will support PhD candidates from Asia and Africa to lead work to evaluate antimicrobial prescribing practices in critical care and implement antimicrobial stewardship programs, included registry enabled audit and feedback, and stewardship guidelines.
NICST’s continues its collaboration with University College London and AIGHD (The Netherlands), to facilitate opportunities for higher education (MSc) in perioperative medicine and fellowships in global health and quality improvement methods for healthcare workers, primarily from LMICs. . The work continues to support the QI and education platform whereby experts and clinicians from LMICs provide resources for health care professionals seeking to improve the quality and experience of care for patients in Asia and Africa. This resource will be leveraged in the ongoing Wellcome CCAA network.
NICST has sought to translate learning from projects in LMICs to support improving care for critically ill patients in the UK. In partnership with the University of Hertfordshire, NICST has supported the development and pilot of a patient and family communication application. The pilot and evaluation is currently in progress and will be reported 2022-23.
The partnership with Doctors with Africa and local health care workers in Freetown, Sierra Leone, established in 2018 with Doctors with Africa,an Italian based NGO https://doctorswithafrica.org/, has matured and expanded to include Ethiopia, Sudan and Sierra Leone with a focus on maternal and infant health. This partnership has been central in the expansion of the CRIT Care Asia- Africa network.
NICST and NICS MORU continue their partnership with AIGHD (Netherlands) (established in 2019) to provide opportunities for new career researchers and clinicians to engage in bi directional research programmes. Nine academic fellows have successfully completed MSc in perioperative medicine and global health, contributing to the charity's projects in Asia and Africa. The perioperative registry (initiated in 2019) has led to the evaluation of clinical care using a series of perioperative care outcome measures which focus on the essentials of safe surgical care; airway management, safe surgery checklist, pain relief, cardiovascular and airway support, recognition of infection and early mobilisation and a national landscaping of critical care service capacity in the region. This work has been published in peer reviewed journals. More information about this collaboration can be found here.
Building on this progress, NICST is currently contributing to the Lancet Commissions, Utstein metric for Perioperative outcome metric. Researchers based with NICST are supporting the development of an international dataset to benchmark outcomes for surgical activity and critically ill surgical patients.
Founded in 2019, the collaboration between University of Birmingham, Institute of Applied Health Research and University of Jaffna, Department of Community and Family Medicine has continued to flourish. The partnership has resulted in the successful completion of health services evaluation of existing AF and NCD pathways in Sri Lanka,identifying barriers to quality of NCD care. This published work is now informing the development of patient led community engagement programmes to improve access and referral for NCD community care. This work to be commenced in 2022, will be undertaken by clinicians and PhD candidates based in Sri Lanka. This work is part of an NIHR funded Global Health Research Group for AF management; spanning Brazil, Sri Lanka and China. NICST continues to support Sri Lanka based collaborators (University
5
of Jaffna) with the evaluation and improvement of existing community to tertiary management of AF. This project has recruited a longitudinal cohort for over 10,000 patients to monitor incidence and prevalence of non communicable disease, for which NICST is supporting coordination and curation of the data and supporting utilisation of the data for analysis. Work published to date can be found here. .
NICST/NICS-MORU enabled the conduct of the WHO observational study O2Cov2 for Covid-19 patients in LMIC. https://clinicaltrials.gov/ct2/show/NCT04918875. Its role included clinical research support and coordination of ethics and regulatory processes across 30 countries, support with training and study implementation and liaising between countries study teams and the WHO central office.
## **3.0 Structure, Governance and Management**
## _3.1 Structure_
The charity is constituted as a charitable incorporated organisation (CIO) and is governed by a CIO foundation constitution constituted in 2017. The CIO’s organisational structure consists of a trustee board of five first trustees.The CIOs trustees all contribute without remuneration or pay in accordance with the CIOs foundation constitution. All decisions related to the structure and governance of the CIO are made by the members of the CIO acting on behalf of the charity. As set out in our governing document, every charity trustee is a natural person, older than 16 years of age. Any new trustee will be appointed for a minimum of three years by resolution and formal meeting of the trustees. Regard for skills, expertise and experience to the contribution of the CIO is considered when selecting new trustees. Prior to appointment of a trustee the following will be made available to the trustee: a copy of the governing document, a copy of the CIO’s most recent annual report, and a copy of the charity’s accounts for the most recent financial year. Trustees are required to disclose all relevant interests and register them with the CIO and in accordance with the charities policy withdraw from decisions where a conflict of interest arises. No trustees have declared interests (except as stated above) which conflict with their role in the CIO.
## _3.2 Governance and management_
The CIO does not employ any management or committees to act on its behalf. The trustees aim to meet face to face twice a year, with a minimum of a quorum in attendance **.** With the continuation of travel and social distancing restrictions due to the COVID-19 pandemic, the trustee meeting was held remotely in the first quarter in March 2021. All trustees were in attendance. Email communication to implement the actions of the meeting were completed during the second and third quarters of 2021. These communications are archived for accountability and audit. A minimum of 2 trustees are in attendance for any decision to be made. Questions arising at meetings are decided by an eligible majority. In the case of equality of vote the chair will cast a second vote. A chair is appointed for each meeting and has responsibility for the accurate recording, reporting, dissemination and storage of minutes and decisions.
## _3.3 Monitoring achievement_
The success of the charity’s activities is evaluated by the successful collaboration of the charity with universities, research institutions and the LMIC health care community. Success is further measured by the award of funding for academic research and development from UK and foreign scientific and philanthropic funding agencies. Translational research success is assessed by the timely completion of planned research projects and the publications in peer reviewed journals. The outcome of the research is also assessed by the identification of the changes or improvements to clinical or care practices stemming from the research.
6
## _3.4 Summary of achievements_
||||
|---|---|---|
|**Objective**|**Measure**|**This reporting period**|
|1-4|Peer reviewed scientific publications|24|
|1-4|International conference presentations|Online given COVID-19
pandemic|
|2.2|Registry activity (patient episodes)|Continuing quality evaluation
across over 260 units in 17
countries|
|2.5|Academic fellows / graduate exchanges|9 (100 % completed)|
|2.4|Research projects conducted and completed|4 (2 project completed, 2
remain in progress (as
expected)|
## _3.5 Trustees’ responsibilities in relation to the financial statements_
The charity trustees are responsible for preparing a trustees’ annual report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England and Wales requires the charity trustees to prepare financial statements for each year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, of the charity for that period. In preparing the financial statements, the trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the applicable Charities SORP;
- make judgements and estimates that are reasonable and prudent;
- state whether applicable accounting standards have been followed, subject to any material departures that must be disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations, and the
7
provisions of the CIO foundation constitution. They are also responsible for safeguarding the assets of the charity and taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the charity and financial information included on the charity’s website in accordance with legislation in the United Kingdom governing the preparation and dissemination of financial statements.
## **4.0 Contribution made by volunteers**
The charity and its trustees and beneficiaries are very grateful to the volunteers who contribute to achieving the aims and objectives during this period. Given the global travel restrictions of COVID-19, the international fellowship 2021-22 period, Ms Eva Slujis, an MSc Global Health student successfully participated in an online international stakeholder quality indicator prioritizations research project. This work has been published and is now forming the foundation for data surveillance for PhD candidates from India, Pakistan and Afghanistan in implementing antimicrobial stewardship(AMS) programmes in 2022 onwards. Ms Alba Korver and Dr Patirck Chappell, both MSc Global Health students from AIGHD and UCL respectively will be the NICST fellows for 2022, undertaking mixed methods research reviews of implementation science methods in LMICs. Volunteers continue to be supported by a trustee to mentor them in their voluntary contributions. Support during overseas work (suspended for 2020-22) was provided by a support crew with face to face and remote communication as required.
## **5.0 Financial Review**
## _5.1 Trustee Financial statement_
The trustees have prepared the financial report for the period in accordance with legislation in the United Kingdom governing the preparation and dissemination of financial statements. The trustees confirm that proper accounting records disclose with reasonable accuracy the financial position of the charity and that these records comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations, and the provisions of the CIO foundation constitution. They can report that there are no irregularities within the financial reports for this period. As per the Charities Act 2011, they have sought independent review from Hines Harvey Woods Limited.
## _5.2 Financial report._
The charity has no investments or endowments. The charity received £123,951 during the reporting period. The charity’s principal sources of funds during the period were in services to the WHO (£87834.92) and Monash University for the implementation of REMAP-CAP (£34570.81). The remainder was for registry implementation, data coordination and clinical research support services for the Wellcome- Oxford (MORU) CCAA. The charity allocated funds to support the activities to achieve objectives 1- 5. During the financial year the charity’s expenditure was £2753 ~~718933,~~ of which £17,092 was in charitable donations and £8604 was rechargeable to MORU, Thailand. Repayments of £ 5821.41 from Monash and 2479.19 owed by MORU (Thailand) were repaid to the charity. The charity currently has no investments but its trustees are aware of the social investment policy. The charity faces no financial uncertainties for the next financial year. Funds have been secured to meet the projected commitments and the current deficit of the charity. The charity has no subsidiary undertakings.
## **6.0 Risk management**
8
## **7.0 Future plans for the charity**
NICST’s success in achieving their charitable objectives in 2021-22 is a testimony to the generosity of the volunteers contributions and the productivity of the collaboration with NICS- MORU and other healthcare organisations, now funded by international grant awarding bodies. The trustees’ will continue to prioritise promoting the development of clinical training for healthcare professionals, clinical teams and healthcare services, and advancing translational research. We continue to work with our key partners in NICS- MORU and Doctors with Africa to develop and deliver clinical training programmes. We will build on the collaborations with University College London, University of Oxford, UKRI/ MRC and Wellcome, with whom we have common goals to undertake translational research. An area of fresh focus will be the development of context relevant quality evaluation and improvement methods with a specific focus on improving primary- secondary and tertiary care pathways, AMS and improved ventilation practices This new focus complements the established objective of ‘establishing and developing data platforms to enable better patient care in LMICs.’ This will benefit the public by providing frontline healthcare teams with information to evaluate existing care, identify areas where quality of care is not as expected and identify priorities for care improvement.
Our medium term goals for 2022- 2023 will be to further the establishment and development of a community of practice to improve the quality of acute care LMICs through south to south collaboration. To achieve this goal, NICST will continue to partner with NICS-MORU and with Mahidol Oxford Tropical Research Unit, (MORU), Wellcome and the UKRI/ MRC with a planned acute and critical care collaboration across 17 countries in Asia and Africa. In addition we seek to strengthen international research partnerships with the University of Jaffna, University of British Colombia, and Monash University, Australia. NICST’s role in this collaboration will be to train healthcare workers in the skills to undertake research including clinical trials and service improvement for patients internationally.
## **8.0 Declarations**
The trustees declare that they have approved the trustees’ report above. Each trustee is an expert active in the field in which the charity operates. This means we are assured that their technical knowledge is up to date and that they have the depth of insight to effectively evaluate the appropriateness of the objectives, activities and charitable donations to NICS-MORU. They are further accountable to the wider academic community in which they stand and projects output, which includes scientific publications, are reviewed by peers within the scientific community.
**Signed on behalf of the charity’s trustees:**
**Full name:** Abigail Beane
9
## **Position:** Chair.
**Date** 17th January 2023
## **References**
1. Valentin A, Ferdinande P, ESICM Working Group on Quality Improvement: Recommendations on basic requirements for intensive care units: structural and organizational aspects. Intensive Care Med 2011; 37:1575–87
2. Baker T: Critical care in low-income countries. Trop Med Int Heal 2009; 14:143–148
3. Beane A, Stephens T, Silva AP De, et al.: A sustainable approach to training nurses in acute care skills in a resource limited setting (Network for Intensive Care Skills Training, NICST). Resuscitation 2016; 101:e1–e2
4. De Silva AP, Stephens T, Welch J, et al.: Nursing intensive care skills training: A nurse led,short, structured, and practical training program, developed and tested in a resource- limited setting. J Crit Care 2015; 30:438.e7-438.e11
5. Stephens T, De Silva AP, Beane A, et al.: Capacity building for critical care training delivery: Development and evaluation of the Network for Improving Critical care Skills Training (NICST) programme in Sri Lanka. Intensive Crit Care Nurs 2017; 39:28–36
6. De Silva, A.P., Sujeewa, J.A., De Silva, N., Rathnayake, R.M.D., Vithanage, L., Sigera, P.C., Munasinghe, S., Beane, A., Stephens, T., Athapattu, P.L. and Jayasinghe, K.S.A., 2017. A retrospective study of physiological observation-reporting practices and the recognition, response, and outcomes following cardiopulmonary arrest in a low-to-middle-income country. Indian Journal of Critical Care Medicine, 21(6), p.343.
7. Beane A, De Silva AP, De Silva N, Sujeewa JA, Rathnyake RMSigera PC, Dondopr AM, HAniffa R. 2017. Evaluation of the feasibility and performance of existing early warning systems to identify patients at risk of adverse outcomes in a low- middle income country setting. ESICM Lives 2017, Vienna.
8. Haniffa R, Lubell Y, Cooper BS, Mohanty S, Alam S, Karki A, Pattnaik R, Maswood A, Haque R, Pangeni R, Schultz MJ. Impact of a structured ICU training programme in resource-limited settings in Asia. PloS one. 2017 Mar 14;12(3):e0173483.
## **Publications and scientific output.**
These are now available on request. Please email abi@nicslk.com for more information.
10
||Network for Improving Critical-Care Systems and Training|Network for Improving Critical-Care Systems and Training|Network for Improving Critical-Care Systems and Training|Charity No
(ifany)|1171106||
|---|---|---|---|---|---|---|
||Annualaccountsforthe period||||||
||Period start date|01-Apr-21|**To**|Period end
date|31-Mar-22||
||||||||
|**Section A**|**Statement of financial activities**||||||
|**Recommended categories by**
**activity**
Guidance Notes
**Incoming resources (Note 3)**
**Income and endowments from:**
Donations and legacies
S01
Charitable activities
S02
Other trading activities
S03
Investments
S04
Separate material item of income
S05
Other
S06
S07
**Resources expended (Note 6)**
**Expenditure on:**
Raising funds
S08
Charitable activities
S09
Separate material item of expense
S10
Other
S11
S12
S13
Net gains/(losses) on investments
S14
S15
**Extraordinary items**
S16
S17
S18
Other gains/(losses)
S19
S20
**_Reconciliation of funds:_**
S21
S22
1
**_Total_**
**_Net movement in funds_**
Total funds brought forward
**_Total funds carried forward_**
**_Total_**
**Net income/(expenditure) before investment**
**gains/(losses)**
**Net income/(expenditure)**
**Transfers between funds**
**Other recognised** **gains/(losses):**
Gains and losses on revaluation of fixed assets for the charity’s own use||**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**funds**
**£**
**£**
**£**
**£**
**£**
F01
F02
F03
F04
F05|||||
|||123,951|-|-|123,951|62,514|
||||-|-|-|-|
|||8,604|-|-|8,604|-|
|||-|-||-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||132,555|-|-|132,555|62,514|
||||||||
|||-|-|-|-|-|
|||17,092|-|-|17,092|9,416|
|||8,604|-|-|8,604|-|
|||1,841|-|-|1,841|660|
|||27,537|-|-|27,537|10,076|
||||||||
|||105,018|-|-|105,018|52,438|
|||-|-|-|-|-|
|||105,018|-|-|105,018|52,438|
|||-|-|-|-|-|
|||-|-|-|-|-|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
|||105,018|-|-|105,018|52,438|
||||||||
|||36,243|-|-|36,243|16,195
-|
|||141,261|-|-|141,261|36,243|
||||||||
## **Section B Balance sheet**
|**Fixed assets**
**Intangible assets (Note 15)**
**Tangible assets (Note 14)**
**Heritage assets (Note 16)**
**Investments (Note 17)**
**_Total fixed assets_**
**Current assets**
**Stocks (Note 18)**
**Debtors (Note 19)**
**Investments (Note 17.4)**
**Cash at bank and in hand (Note 24)**
**_Total current assets_**
**Creditors: amounts falling due within**
**one year (Note 20)**
**_Net current assets/(liabilities)_**
**_Total assets less current liabilities_**
**Creditors: amounts falling due after**
**one year (Note 20)**
**Provisions for liabilities**
**_Total net assets or liabilities_**
**Funds of the Charity**
**Endowment funds (Note 27)**
**Restricted income funds (Note 27)**
**Unrestricted funds**
**Revaluation reserve**
**_Total funds_**
Signed by one or two trustees on behalf of all
the trustees|Guidance Notes
B01
B02
B03
B04
B05
B06
B07
B08
B09
B10
B11
B12
B13
B14
B15
B16
B17
B18
B19
B20
B21|**Unrestricted**
**funds**
**£**
F01|
**Restricted**
**income**
**funds**
**£**
F02|**Endowment**
**funds**
**Total this**
**year**
**£**
**£**
F03
F04|**Endowment**
**funds**
**Total this**
**year**
**£**
**£**
F03
F04|**Total last**
**year**
**£**
F05|
|---|---|---|---|---|---|---|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
||||||||
|||-|-|-|-|-|
|||49,305|-|-|49,305|15,120|
|||-|-|-|-|-|
|||92,592|-|-|92,592|22,328|
|||141,897|-|-|141,897|37,448|
||||||||
|||636|-|-|636|1,205|
||||||||
|||141,261|-|-|141,261|36,243|
||||||||
|||141,261|-|**-**|141,261|36,243|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
||||||||
|||141,261|-|-|141,261|36,243|
||||||||
|||-|||-|-|
||||-||-|-|
|||||-|-|-|
||||||-||
|||-|-|-|-|-|
||||||||
|||Signature||Print Name||Date of
approval
dd/mm/yyyy|
|||||Abigail Beane||27/01/23|
|||||Rashan Haniffa||27/01/23|
CC17a (Excel)
26/01/2023
2
## **Section C Notes to the accounts**
## Note 1 **Basis of preparation**
_**This section should be completed by all charities**_ _`.`_
## **1.1 Basis of accounting**
These accounts have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these accounts.
The accounts have been prepared in accordance with:
- the Statement of Recommended Practice: Accounting and Reporting by Charities
- • and with* **�** preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) issued on 16 July 2014
- and with* **�** the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102)
- and with the Charities Act 2011.
The charity constitutes a public benefit entity as defined by � FRS 102.*
- -Tick as appropriate
## **1.2 Going concern**
_**If there are material uncertainties related to events or conditions that cast significant doubt on the charity's ability to continue as a going concern, please provide the following details or state "Not applicable", if appropriate:**_
An explanation as to those factors that support the conclusion that the charity is a going concern; Disclosure of any uncertainties that make the going concern assumption doubtful; Where accounts are not prepared on a going concern basis, please disclose this fact together with the basis on which the trustees prepared the accounts and the reason why the charity is not regarded as a going concern.
## **1.3 Change of accounting policy**
The accounts present a true and fair view and the accounting policies adopted are those outlined in note { }.
Yes* **�** * -Tick as appropriate No*
## _**Please disclose:**_
_**(i) the nature of the change in accounting policy; (ii) the reasons why applying the new accounting policy provides more reliable and more relevant information; and**_
CC17a (Excel)
26/01/2023
3
_**(iii) the amount of the adjustment for each line affected in the current period, each prior period presented and the aggregate amount of the adjustment relating to periods before those presented, 3.44 FRS 102 SORP.**_
## **1.4 Changes to accounting estimates**
No changes to accounting estimates have occurred in the reporting period (3.46 FRS 102 SORP).
**----- Start of picture text -----**
Yes* �
* -Tick as appropriate
No*
**----- End of picture text -----**
## _**Please disclose:**_
**----- Start of picture text -----**
(i) the nature of any changes;
(ii) the effect of the change on income and expense or
assets and liabilities for the current period; and
(iii) where practicable, the effect of the change in one or
more future periods.
**----- End of picture text -----**
## **1.5 Material prior year errors**
No material prior year error have been identified in the reporting period (3.47 FRS 102 SORP).
**----- Start of picture text -----**
Yes* �
* -Tick as appropriate
No*
**----- End of picture text -----**
## _**Please disclose:**_
_**(i) the nature of the prior period error; (ii) for each prior period presented in the accounts, the amount of the correction for each account line item affected; and**_
_**(iii) the amount of the correction at the beginning of the earliest prior period presented in the accounts.**_
CC17a (Excel)
26/01/2023
4
## **Section C Notes to the accounts**
## **Note 2 Accounting policies**
```
Please complete this note when first reporting under FRS2102. Section 35 of FRS102, requires 3 reconciliations to be
presented, if all are applicable.
```
## **2.1 RECONCILIATION WITH PREVIOUS GENERALLY ACCEPTED ACCOUNTING PRACTICE**
**Please provide a description of the nature of each change in accounting policy**
## _**Reconcilation of funds per previous GAAP to funds determined under FRS 102**_
**Start of End of period period £ £ Fund balances as previously stated** _**Adjustments:**_
## **Fund balance as restated**
## _**Reconcilation of net income/(net expenditure) per previous GAAP to net income/(net expenditure) under FRS 102**_
**End of £ Net income/(expenditure) as previously stated** _**Adjustments:**_ **Previous period net income/(expenditure) as restated**
CC17a (Excel)
26/01/2023
5
**Section C Notes to the accounts (cont)**
## **Note 2 Accounting policies 2.2 INCOME**
```
This standard list of accounting policies has been applied by the charity except for those ticked "No" or "N/a". Where a
different or additional policy has been adopted then this is detailed in the box below.
```
|**Recognition of income**
Donated services and facilities that are consumed immediately are recognised as
income with an equivalent amount recognised as an expense under the appropriate
heading in the SOFA.
The cost of any stock of goods donated for distribution to beneficiaries is deemed to be
the fair value of those gifts at the time of their receipt and they are recognised on
receipt. In the reporting period in which the stocks are distributed, they are recognised
as an expense at the carrying amount of the stocks at distribution.
**Donated services and**
**facilities**
Donated services and facilities are included in the SOFA when received at the value of
the gift to the charity provided the value of the gift can be measured reliably.
**Income from interest,**
**royalties and dividends**
This is included in the accounts when receipt is probable and the amount receivable can
be measured reliably.
**Income from membership**
**subscriptions**
Membership subscriptions received in the nature of a gift are recognised in Donations
and Legacies.
These are included in the Statement of Financial Activities (SoFA) when:
• the charity becomes entitled to the resources;
· it is more likely than not that the trustees will receive the resources; and
• the monetary value can be measured with sufficient reliability.
**Donated goods**
**Contractual income and**
**performance related**
**grants**
**Offsetting**
There has been no offsetting of assets and liabilities, or income and expenses, unless required
or permitted by the FRS 102 SORP or FRS 102.
**Grants and donations**
Grants and donations are only included in the SoFA when the general income
recognition criteria are met (5.10 to 5.12 FRS102 SORP).
This is only included in the SoFA once the charity has provided the related goods or
services or met the performance related conditions.
Donated goods are measured at fair value (the amount for which the asset could be
exchanged) unless impractical to do so.
In the case of performance related grants, income must only be recognised to the extent
that the charity has provided the specified goods or services as entitlement to the grant
only occurs when the performance related conditions are met (5.16 FRS 102 SORP).
**Legacies**
Legacies are included in the SOFA when receipt is probable, that is, when there has
been grant of probate, the executors have established that there are sufficient assets in
the estate and any conditions attached to the legacy are either within the control of the
charity or have been met.
**Government grants**
The charity has received government grants in the reporting period
**Tax reclaims on**
**donations and gifts**
Gift Aid receivable is included in income when there is a valid declaration from the
donor. Any Gift Aid amount recovered on a donation is considered to be part of that gift
and is treated as an addition to the same fund as the initial donation unless the donor or
the terms of the appeal have specified otherwise.
Gifts in kind for use by the charity are included in the SoFA as income from donations
when receivable.
**Support costs**
The charity has incurred expenditure on support costs.
**Volunteer help**
Donated goods for resale are measured at fair value on initial recognition, which is the
expected proceeds from sale less the expected costs of sale, and recognised in 'Income
from other trading activities' with the corresponding stock recognised in the balance
sheet. On its sale the value of stock is charged against 'Income from other trading
activities' and the proceeds from sale are also recognised as 'Income from other trading
activities'.
Goods donated for on-going use by the charity are recognised as tangible fixed assets
and included in the SoFA as incoming resources when receivable.
The value of any voluntary help received is not included in the accounts but is described
in the trustees’ annual report.|Yes
No
N/a|Yes
No
N/a|Yes
No
N/a|
|---|---|---|---|
||**�**|||
||Yes
No
N/a|||
||**�**|||
||Yes
No
N/a|||
||**�**|||
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
|||**�**||
||Yes
No
N/a|||
||**�**|||
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
||Yes
No
N/a|||
||||**�**|
|**2.4 ASSETS**
**Intangible fixed assets**
**Heritage assets**
**Stocks and work in**
**progress**
Stocks held for sale as part of non-charitable trade are measured at the lower or cost or net
realisable value.
Support costs include central functions and have been allocated to activity cost
categories on a basis consistent with the use of resources, eg allocating property costs
by floor areas, or per capita, staff costs by the time spent and other costs by their
usage.
They are valued at cost.
**Investments**
Fixed asset investments in quoted shares, traded bonds and similar investments are
valued at initially at cost and subsequently at fair value (their market value) at the year
end. The same treatment is applied to unlisted investments unless fair value cannot be
measured reliably in which case it is measured at cost less impairment.
Investments held for resale or pending their sale and cash and cash equivalents with a
maturity date of less than 1 year are treated as current asset investments
**Grants with performance**
**conditions**
Where the charity gives a grant with conditions for its payment being a specific level of
service or output to be provided, such grants are only recognised in the SoFA once the
recipient of the grant has provided the specified service or output.
**Grants payable without**
**performance conditions**
Where there are no conditions attaching to the grant that enables the donor charity to
realistically avoid the commitment, a liability for the full funding obligation must be
recognised.
The charity has intangible fixed assets, that is, non-monetary assets that do not have
physical substance but are identifiable and are controlled by the charity through custody
or legal rights. The amortisation rates and methods used are disclosed in note 9.5
They are valued at cost.
The charity has heritage assets, that is, non-monetary assets with historic, artistic,
scientific, technological, geophysical or environmental qualities that are held and
maintained principally for their contribution to knowledge and culture. The depreciation
rates and methods used as disclosed in note 9.6.1.4.
This includes any realised or unrealised gains or losses on the sale of investments and
any gain or loss resulting from revaluing investments to market value at the end of the
year.
Membership subscriptions which gives a member the right to buy services or other
benefits are recognised as income earned from the provision of goods and services as
income from charitable activities.
**2.3 EXPENDITURE AND LIABILITIES**
**Liability recognition**
Liabilities are recognised where it is more likely than not that there is a legal or
constructive obligation committing the charity to pay out resources and the amount of
the obligation can be measured with reasonable certainty.
**Investment gains and**
**losses**
The charity accounts for basic financial instruments on initial recognition as per
paragraph 11.7 FRS102 SORP. Subsequent measurement is as per paragraphs 11.17
to 11.19, FRS102 SORP.
**Tangible fixed assets for**
**use by charity**
The depreciation rates and methods used are disclosed in note 9.2.
**Governance and support**
**costs**
Support costs have been allocated between governance costs and other support.
Governance costs comprise all costs involving public accountability of the charity and its
compliance with regulation and good practice.
**Settlement of insurance**
**claims**
Insurance claims are only included in the SoFA when the general income recognition
criteria are met (5.10 to 5.12 FRS102 SORP) and are included as an item of other
income in the SoFA.
They are valued at cost.
These are capitalised if they can be used for more than one year, and cost at least
**Redundancy cost**
The charity made no redundancy payments during the reporting period.
**Deferred income**
No material item of deferred income has been included in the accounts.
**Creditors**
The charity has creditors which are measured at settlement amounts less any trade
discounts
**Provisions for liabilities**
A liability is measured on recognition at its historical cost and then subsequently
measured at the best estimate of the amount required to settle the obligation at the
reporting date
**Basic financial**
**instruments**||Yes
No
N/a|Yes
No
N/a|Yes
No
N/a|
|---|---|---|---|---|
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||**�**
|||
|||Yes
No
N/a|||
|||**�**|||
|||Yes
No
N/a|||
|||**�**|||
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||**�**|||
|||Yes
No
N/a|||
|||**�**|||
|||Yes
No
N/a|||
|||**�**|||
|||Yes
No
N/a|||
|||**�**|||
|||Yes
No
N/a|||
|||**�**|||
|||Yes
No
N/a|||
||||||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
|||Yes
No
N/a|||
|||||**�**|
Yes No N/a Goods or services provided as part of a charitable activity are measured at net realisable value based on the service potential provided by items of stock. **�** Yes No N/a Work in progress is valued at cost less any foreseeable loss that is likely to occur on the contract. **�** Debtors (including trade debtors and loans receivable) are measured on initial recognition at Yes No N/a **Debtors** settlement amount after any trade discounts or amount advanced by the charity. Subsequently, **�** they are measured at the cash or other consideration expected to be received. The charity has has investments which it holds for resale or pending their sale and cash and Yes No N/a **Current asset** cash equivalents with a maturity date less than one year. These include cash on deposit and **investments** cash equivalents with a maturity date of less than one year held for investment purposes rather **�** than to meet short term cash commitments as they fall due. Yes No N/a They are valued at fair value except where they qualify as basic financial instruments.
|Yes
No
N/a|Yes
No
N/a|Yes
No
N/a|Yes
No
N/a|
|---|---|---|---|
|||**�**||
|Yes
No
N/a||||
|**�**||||
|Yes
No
N/a||||
|||**�**||
|Yes
No
N/a||||
|||**�**||
|||||
**POLICIES ADOPTED ADDITIONAL TO OR DIFFERENT FROM THOSE ABOVE**
**Section C Notes to the accounts (cont)**
## **Note 3 Analysis of income**
|**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**£**
**£**
Donations andgifts
- - - -3,991
Gift Aid
- - - - -
Services
123,951
- - 123,951 27,695
General grants provided by government/other
charities
- - - -30,828
Membership subscriptions and sponsorships
which are in substance donations
- - - -
Donatedgoods,facilities and services
- - - - -
Other
- - -
**Total** 123,951 - - 123,951 62,514
- - - - -
- - - - -
- - - - -
Other
- - - - -
**Total**
- - - - -
- - - - -
- - - - -
- - - - -
Other
8,604
- -8,604
-
**Total** 8,604 - -8,604
-
Interest income
- - - - -
Dividend income
- - - - -
Rental and leasingincome
- - - - -
Other
- - - - -
**Total**
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
**Total**
- - - - -
Conversion of endowment funds into income
- - - - -
Gain on disposal of a tangible fixed asset
held for charity's own use
- - - - -
Gain on disposal of a programme related
investment
- - - - -
Royalties from the exploitation of intellectual
propertyrights
- - - - -
Other
- - - - -
**Total**
- - - - -
132,555 - - 132,555 62,514
**Other information:**
**TOTAL INCOME**
**Other:**
**Other trading**
**activities:**
**Income from**
**investments:**
**Separate**
**material item**
**of income:**
**Analysis**
**Donations**
**and legacies:**
**Charitable**
**activities:**|**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**£**
**£**
**Analysis**|**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**£**
**£**
**Analysis**|**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**£**
**£**
**Analysis**|**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**£**
**£**
**Analysis**|**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**£**
**£**
**Analysis**|**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**Prior year**
**£**
**£**
**Analysis**|
|---|---|---|---|---|---|---|
||Donations andgifts|-|-|-|-|3,991|
||Gift Aid|-|-|-|-|-|
||Services|123,951|-|-|123,951|27,695|
||General grants provided by government/other
charities|
-|-|-|-|30,828|
||Membership subscriptions and sponsorships
which are in substance donations|-|-|-|-||
||Donatedgoods,facilities and services|-|-|-|-|-|
||Other||-|-|-||
||**Total**|123,951|-|-|123,951|62,514|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
||Other|-|-|-|-|-|
||**Total**|-|-|-|-|-|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
||Other|8,604|-|-|8,604|-|
||**Total**|8,604|-|-|8,604|-|
||||||||
||Interest income|-|-|-|-|-|
||Dividend income|-|-|-|-|-|
||Rental and leasingincome|-|-|-|-|-|
||Other|-|-|-|-|-|
||**Total**|-|-|-|-|-|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
||**Total**|-|-|-|-|-|
||||||||
||Conversion of endowment funds into income|-|-|-|-|-|
||Gain on disposal of a tangible fixed asset
held for charity's own use|-|-|-|-|-|
||Gain on disposal of a programme related
investment|-|-|-|-|-|
||Royalties from the exploitation of intellectual
propertyrights|-|-|-|-|-|
||Other|-|-|-|-|-|
||**Total**|-|-|-|-|-|
||||||||
|||132,555|-|-|132,555|62,514|
||||||||
|**All income in the prior year was unrestricted except for:**
**(please provide description and amounts)**|||||||
|**Where any endowment fund is converted into income in the**
**prior period, please give the reason for the conversion.**
**Where any endowment fund is converted into income in the**
**reporting period, please give the reason for the conversion.**|||||||
||||||||
||||||||
||||||||
||||||||
|**Within the income items above the following items are**
**material: (please disclose the nature, amount and any prior**
**year amounts)**|||||||
CC17a (Excel)
26/01/2023
9
**Section C Notes to the accounts (cont)**
## **Note 4 Analysis of receipts of government grants**
|**Government grant 1**
**Government grant 2**
**Government grant 3**
**Other**
**Government grant 1**
**Government grant 2**
**Government grant 3**
**Other**
**_Please provide details of any_**
**_unfulfilled conditions and other_**
**_contingencies attaching to grants_**
**_that have been recognised in income._**
**_Please give details of other forms of_**
**_government assistance from which_**
**_the charity has directly benefited._**|**This year**
**£**
**Description**|**This year**
**£**
**Description**|**This year**
**£**
**Description**|
|---|---|---|---|
||||-|
||||-|
||||-|
||||-|
||**Total**
**Description**||-|
||||**Last year**
**£**|
||||-|
||||-|
||||-|
||||-|
||**Total**
-
**Thisyear**
**Lastyear**||-|
|||||
||**Thisyear**
**Lastyear**|||
|||||
CC17a (Excel)
26/01/2023
10
**Section C Notes to the accounts (cont)**
## **Note 5 Donated goods, facilities and services**
|**Use of property**
**Other**
**Seconded staff**|**Thisyear**|**This year**
**Last year**
**£**
**£**|**This year**
**Last year**
**£**
**£**|
|---|---|---|---|
|||-|-|
|||-|-|
|||-|-|
|||-|-|
|||||
|||**Lastyear**||
|**Please provide details of the**
**accounting policy for the recognition**
**and valuation of donated goods,**
**facilities and services.**||||
|**Please provide details of any**
**unfulfilled conditions and other**
**contingencies attaching to resources**
**from donated goods and services not**
**recognised in income.**
**Please give details of other forms of**
**other donated goods and services not**
**recognised in the accounts, eg**
**contribution of unpaid volunteers.**||||
|||||
|||||
|||||
CC17a (Excel)
26/01/2023
11
## **Section C Notes to the accounts (cont)**
## **Note 6 Analysis of expenditure**
|**Note 6 Analysis of**|**expenditure**|**expenditure**|**expenditure**|**expenditure**|**expenditure**|**expenditure**|**expenditure**|**expenditure**|
|---|---|---|---|---|---|---|---|---|
|**Analysis**
**Expenditure on raising funds:**|**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Total funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Total funds**
**£**
**£**
**This year**
**Last year**||||||||
|Incurred seeking donations|-|-|-|-|-|-|-|-|
|Incurred seeking legacies|-|-|-|-|-|-|-|-|
|Incurred seeking grants|-|-|-|-||||-|
|Operating membership schemes and
social lotteries|-|-|-|-||||-|
|Staging fundraising events|-|-|-|-||||-|
|Fudraising agents|-|-|-|-||||-|
|Operating charity shops|-|-|-|-||||-|
|Operating a trading company
undertaking non-charitable trading
activity|-|-|-|-||||-|
|Advertising, marketing, direct mail and
publicity|-|-|-|-|-|-|-|-|
|Start up costs incurred in generating
new source of future income|-|-|-|-|-|-|-|-|
|Database development costs|-|-|-|-|-|-|-|-|
|Other trading activities|-|-|-|-||||-|
|Investment management costs:|-|-|-|-||||-|
|Portfolio management costs|-|-|-|-|-|-|-|-|
|Cost of obtaining investment advice|-|-|-|-|-|-|-|-|
|Investment administration costs|-|-|-|-|-|-|-|-|
|Intellectual property licencing costs|-|-|-|-|-|-|-|-|
|Rent collection, property repairs and
maintenance charges|-|-|-|-|-|-|-|-|
||-|-|-|-|-|-|-|-|
|**Total expenditure on raising funds**|-|-|-|-|-|-|-|
-|
|**Expenditure on charitable activities:**|||||||||
|Cloud computing|8,604|-|-|8,604|-|-|-|-|
|Charitable donations|17,092|-|-|17,092|8,443||-|8,443|
|Office expenses|-|-|-|-|973||-|973|
||-|-|-|-|-|-|-|-|
|**Total expenditure on charitable**
**activities**|25,696|-|-|25,696|9,416|-|-|9,416|
|**Separate material item of expense**|||||||||
||-|-|-|-|-|-|-|-|
||-|-|-|-|-|-|-|-|
||-|-|-|-|-|-|-|-|
|**Total**|-|-|-|-|-|-|-|
-|
|**Other**|||||||||
|Accountancy|630|-|-|630|660||-|660|
|Insurance|408|-|-|408|-|-|-|-|
|Bank charges|803|-|-|803|-|-|-|-|
||-|-|-|-|-|-|-|-|
|**Total other expenditure**
**TOTAL EXPENDITURE**|1,841|-|-|1,841|660|-|-|660|
||27,537|-|-|27,537|10,076|-|-|10,076|
CC17a (Excel)
26/01/2023
12
**Other information: Analysis of expenditure on charitable activities**
||**Thisyear**|**Thisyear**|**Thisyear**|**Thisyear**|**Lastyear**|**Lastyear**|**Lastyear**|**Lastyear**|
|---|---|---|---|---|---|---|---|---|
|**Activity or programme**|**Activities**
**undertaken**
**directly**|**Grant**
**funding of**
**activities**|**Support**
**Costs**|**Total this**
**year**|**Activities**
**undertaken**
**directly**|**Grant**
**funding of**
**activities**|**Support**
**Costs**|**Total last**
**year**|
||**£**|**£**|**£**|**£**|**£**|**£**|**£**|**£**|
|Activity1|-|-|-|-|-|-|-|-|
|Activity2|-|-|-|-|-|-|-|-|
|Other|-|-|-|-|-|-|-|-|
|**Total**|-|-|-|-|-|-|-|-|
||||||||||
CC17a (Excel)
26/01/2023
13
## **Section C Notes to the accounts (cont)**
## **Note 7 Extraordinary items**
## _**Please explain the nature of each extraordinary item occurring in the period.**_
|**Description**|**This year**
**Last year**
**£**
**£**|**This year**
**Last year**
**£**
**£**|
|---|---|---|
||-|-|
||||
||-|-|
||-|-|
||-|-|
||||
||-|-|
|**s**|-|-|
**Extraordinary item 1 Extraordinary item 2 Extraordinary item 3 Extraordinary item 4 Total extrordinary items**
CC17a (Excel)
26/01/2023
14
## **Section C Notes to the accounts**
## **Note 8 Funds received as agent**
## **01/04/2021 31/03/2022**
## _**8.1 Please complete this note if the charity has agreed to administer the funds of another entity as its agent. Note: If a charity is acting as an agent, it should not recognise the income in the Statement of Financial Activities or the Balance Sheet.**_
|||**Amount received**|**Amount received**|**Amountpaid out**|**Amountpaid out**|**Balance held atperiod end**|**Balance held atperiod end**|
|---|---|---|---|---|---|---|---|
|**Description/name of party**|**Related**
**party (Yes**
**or No)**|**Thisyear**|**Lastyear**|**Thisyear**|**Lastyear**|**Thisyear**|**Lastyear**|
|||**£**|**£**|**£**|**£**|**£**|**£**|
|||-|-|-|-|-|-|
|||-|-|-|-|-|
-|
|||-|-|-|-|-|
-|
|||-|-|-|-|-|-|
|||-|-|-|-|-|
-|
|**Total**||-|-|-|-|-|
-|
## _**8.2 Where a consortia or similar arrangement exists whereby 2 or more charities co-operate to achieve economies in the purchase of goods or services, please discose details of any balances outstanding between any participating members.**_
|**Description/name of party**|**Balance held atperiod end**|**Balance held atperiod end**|
|---|---|---|
||**Thisyear**|**Lastyear**|
||**£**|**£**|
||-|
-|
||-|-|
||-|
-|
||-|-|
||-|-|
|**Total**|-|
-|
CC17a (Excel)
26/01/2023
15
## **Section C Notes to the accounts**
## **Note 9 Support Costs**
## _**Please complete this note if the charity has analysed its expenses using activity categories and has support costs.**_
## **This year**
|**This year**|||||||
|---|---|---|---|---|---|---|
|**Support cost**
**(examples)**|**Raising funds**|**Activity 1**|**Activity 2**|**Activity 3**|**Grand total**|**Basis of allocation**|
||**£**|**£**|**£**|**£**|**£**|**(Describe method)**|
|Governance|-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
|Other|-|-|-|-|-||
|**Total**|-|-|-|-|-||
## **Last year**
|**Last year**|||||||
|---|---|---|---|---|---|---|
|**Support cost**
**(examples)**|**Raising funds**|**Activity 1**|**Activity 2**|**Activity 3**|**Grand total**|**Basis of allocation**|
||**£**|**£**|**£**|**£**|**£**|**(Describe method)**|
|Governance|-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
|Other|-|-|-|-|-||
|**Total**|-|-|-|-|-||
_**Please provide details of the accounting policy adopted for the apportionment of costs between activities and any estimation techniques used to calculate their apportionment.**_
CC17a (Excel)
26/01/2023
16
## **Section C Notes to the accounts**
## **Note 10 Details of certain items of expenditure**
## **10.1 Fees for examination of the accounts**
_**Please provide details of the amount paid for any statutory external scrutiny of accounts and other services provided by your independent examiner. If nothing was paid please enter '0' in the appropriate box(es).**_
|**Other fees (for example: financial advice, consultancy, accountancy services) paid**
**to the independent examiner**
**Independent examiner’s fees**
**Assurance services other than audit or independent examination**
**Tax advisory fees**|**This year**
**£**|**Last year**
**£**|
|---|---|---|
||220|220|
||-|-|
||-|-|
||410
|440|
CC17a (Excel)
26/01/2023
17
## **Section C Notes to the accounts (cont)**
## **Note 11 Paid employees** _**Please complete this note if the charity has any employees.**_
## **11.1 Staff Costs**
|**This year:**
**Salaries and wages**
**Social security costs**
**Other employee benefits**
**Total staff costs**
**Pension costs (defined contribution scheme)**|**This year**
**£**|**Last year**
**£**|
|---|---|---|
||-|-|
||-|-|
||||
||-|-|
||-|-|
||||
||||
**Please provide details of expenditure on staff working for the charity whose contracts are with and are paid by a related party Last year:**
**Please provide details of expenditure on staff working for the charity whose contracts are with and are paid by a related party**
_**Please give details of the number of employees whose total employee benefits (excluding employer pension costs) fell within each band of £10,000 from £60,000 upwards. If there are no such transactions, please enter 'true' in the box provided.**_
**No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000**
|**Band**|**Number of employees**|**Number of employees**|
|---|---|---|
||**This year**
-|**Last year**
-|
|**£60,000 to £69,999**|||
|**£70,000 to £79,999**|-|-|
|**£80,000 to £89,999**|-|-|
|**£90,000 to £99,999**|-|-|
|**£100,000 to £109,999**|-|-|
||||
|**Please provide the total amount paid to key management**
**personnel (includes trustees and senior management) for their**
**services to the charity. For specific amounts paid to trustees, see**
**Note 28.**|||
||**Thisyear**|**Lastyear**|
||**£**|**£**|
||-|-|
CC17a (Excel)
26/01/2023
18
**11.2 Average head count in the year**
**The parts of the charity in which the employees work**
||**This year**
**Number**|**Last year**
**Number**|
|---|---|---|
|**Fundraising**|-|-|
|**Charitable Activities**|-|-|
|**Governance**|-|-|
|**Other**|-|-|
|**Total**|-|-|
## **11.3 Ex-gratia payments to employees and others (excluding trustees)** _**Please complete if an ex-gratia payment is made.**_
|**Please explain the nature of the**
**payment**
**Please state the legal authority or**
**reason for making the payment**|**This year**||
|---|---|---|
||**Last year**||
||||
||**This year**||
||**Last year**||
|**Please state the amount of the payment (or value of any waiver of**
**a right to an asset)**|**Thisyear**|**Lastyear**|
|---|---|---|
||**£**
-|**£**
-|
CC17a (Excel)
26/01/2023
19
## **11.4 Redundancy payments**
## _**Please complete if any redundancy or termination payment is made in the period.**_
|**The nature of the payment (cash, asset**
**etc.)**
**Total amount of payment**
**Please state the accounting policy for any redundancy or**
**termination payments**
**The extent of redundancy funding at the balance sheet date**|**Thisyear**|**Lastyear**|
|---|---|---|
||**£**
-|**£**
-|
||||
||||
||||
||**Thisyear**|**Lastyear**|
||**£**
-|**£**
-|
||||
||||
CC17a (Excel)
26/01/2023
20
**Section C Notes to the accounts (cont)**
## **Note 12 Defined contribution pension scheme or defined benefit scheme accounted for as a defined contribution scheme.**
## _**12.1 Please complete this note if a defined contribution pension scheme is operated.**_
|**Amount of contributions recognised in the SOFA as an expense**|**Thisyear**|**Lastyear**|
|---|---|---|
||**£**
-|**£**|
|||-|
**Please explain the basis for allocating the liability and expense of defined contribution pension scheme between activities and between restricted and unrestricted funds.**
## _**12.2 Please complete this section where the charity participates in a defined benefit pension plan but is unable to ascertain its share of the underlying assets and liabilities.**_
**Please confirm that although the scheme is accounted for as a defined contribution plan, it is a defined benefit plan.**
**Please provide such information as is available about the plan's surplus or deficit and the implications, if any, for the reporting charity for this year and last year, if different**
## _**12.3 Please complete this section where the charity participates in a multi-employer defined benefit pension plan that is accounted for as a defined contribution plan.**_
**Describe the extent to which the charity can be liable to the plan for other entities' obligations under the terms and conditions of the multi-employer plan. If this is different for last year, provide details**
**Provide an explanation of how any liability arising from an agreement with a multi-employer plan to fund a deficit has been determined. If this is different for last year, provide details**
CC17a (Excel)
26/01/2023
21
**Section C Notes to the accounts (cont)**
## **Note 13 Grantmaking**
_**Please complete this note if the charity made any grants or donations which in aggregate form a material part of the charitable activities undertaken.**_
## **This year:**
## **13.1 Analysis of grants paid (included in cost of charitable activities)**
|**Analysis**|**Grants to**
**institutions**|**Grants to individuals**|**Support costs**|**Total**|
|---|---|---|---|---|
||||**£**|**£**|
|Activityorproject 1|-|-|-|-|
|Activityorproject 2|-|-|-|-|
|Activityorproject 3|-|-|-|-|
|Activityorproject 4|-|-|-|-|
|**_Total_**|**-**|**-**|**-**|**-**|
## _**Please enter “Nil” if the charity does not identify and/or allocate support costs.**_
## **13.2 Grants made to institutions**
|**_My charity has made grants to particular institutions that are material in the_**
**_context of its grantmaking. Details of the institution supported, purpose of the_**
**_grant and total paid to each institution is available on the charity's web site._**|**_My charity has made grants to particular institutions that are material in the_**
**_context of its grantmaking. Details of the institution supported, purpose of the_**
**_grant and total paid to each institution is available on the charity's web site._**|**_Yes_**|**_Please provide_**
**_details of charity's_**
**_URL._**|
|---|---|---|---|
|||**_No_**|**_Provide details_**
**_below_**|
|||||
|**Names of institution**|**Purpose**||**Total amount of**
**grantspaid £**|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
|**_TOTAL GRANTS PAID_**
**_Other unanalysed grants_**
**_Total grants to institutions in reporting period_**|||**-**|
||||-|
||||-|
## **Last year:**
## **13.3 Analysis of grants paid (included in cost of charitable activities)**
|**Analysis**|**Grants to**
**institutions**|**Grants to individuals**|**Support costs**
**£**|**Total**
**£**|
|---|---|---|---|---|
|Activityorproject 1|-|-|-|**-**|
|Activityorproject 2|-|-|-|**-**|
CC17a (Excel)
26/01/2023
22
|Activityorproject 3|-|-|-|**-**|
|---|---|---|---|---|
|Activityorproject 4|-|-|-|**-**|
|**_Total_**|**-**|**-**|**-**|**-**|
## _**Please enter “Nil” if the charity does not identify and/or allocate support costs.**_
## **13.4 Grants made to institutions**
|**13.4 Grants made to institutions**|||
|---|---|---|
|**_My charity has made grants to particular institutions that are material in the_**
**_context of its grantmaking. Details of the institution supported, purpose of the_**
**_grant and total paid to each institution is available on the charity's web site._**|**_Yes_**|**_Please provide_**
**_details of charity's_**
**_URL._**|
||**_No_**|**_Provide details_**
**_below_**|
|**Names of institution**|**Purpose**|**Total amount of**
**grantspaid £**|
|---|---|---|
|||-|
|||-|
|||-|
|||-|
|||-|
|||-|
|||-|
|||-|
|||-|
|||-|
|**_TOTAL GRANTS PAID_**
**_Total grants to institutions in reporting period_**
**_Other unanalysed grants_**||**-**|
|||-|
|||-|
CC17a (Excel)
26/01/2023
23
## **Section C Notes to the accounts (cont)**
## **Note 14 Tangible fixed assets** _**Please complete this note if the charity has any tangible fixed assets**_
## **14.1 Cost or valuation**
|**14.1 Cost or valuation**||||||
|---|---|---|---|---|---|
|**Freehold land &**
**buildings**
**Other land &**
**buildings**
**£**
**£**
At the beginning of the year
- -
Additions
- -
Revaluations
- -
Disposals
- -
Transfers *
- -
At end of the year
- -
****Basis**
SL or RB (Straight
Line or Reducing
Balance)
SL or RB
**** Rate**
At beginning of the year
- -
Disposals
- -
Depreciation
- -
Impairment
- -
Transfers*
- -
At end of the year
- -
Net book value at the beginning of the year
- -
Net book value at the end of the year
- -
**14.4 Impairment**
**_This year: Please provide a description of the events and circumstances that led_**
**_to the recognition or reversal of an impairment loss._**
**14.3 Net book value**
**14.2 Depreciation and impairments**|**Freehold land &**
**buildings**
**£**|**Other land &**
**buildings**
**£**|**Plant,**
**machinery and**
**motor vehicles**
**£**|
**Fixtures, fittings**
**and equipment**
**£**|**Total**
**£**|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
|||||||
||SL or RB (Straight
Line or Reducing
Balance)|SL or RB|SL or RB|SL or RB|SL or RB|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
|||||||
|||||||
_**Last year: Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_
|**14.5 Revaluation**
**_the name of independent valuer, if applicable_**
**_the effective date of the revaluation_**
**_If an accounting policy of revaluation is adopted, please provide:_**|**This year**
**Last year**|**This year**
**Last year**|
|---|---|---|
||||
||||
CC17a (Excel)
26/01/2023
24
## _**the methods applied and significant assumptions**_
_**the carrying amount that would have been recognised had the assets been carried under the cost model.**_
- -
## **14.6 Other disclosures**
|**_(iii) Details of the existence and carrying amounts of property, plant and_**
**_equipment to which the charity has restricted title or that are pledged as security_**
**_for liabilities._**
**_(i) Please state the amount of borrowing costs, if any, capitalised in the construction of_**
**_tangible fixed assets and the capitalisation rate used._**
**_(ii) Please provide the amount of contractual commitments for the acquisition of tangible fixed_**
**_assets._**|**Thisyear**|**Lastyear**|
|---|---|---|
||**£**|**£**|
||-|-|
||-|-|
||||
```
* The "transfers" row is for movements between fixed asset categories.
```
```
** Please indicate the method of depreciation by deleting the method not applicable (SL = straight line; RB = reducing balance). Also please
indicate the rate of depreciation: for straight line, what is the anticipated life of the asset (in years); for reducing balance, what is the percentage
annual deduction.
```
CC17a (Excel)
26/01/2023
25
## **Section C Notes to the accounts (cont)**
## **Note 15 Intangible assets** _**Please complete this note if the charity has any intangible assets**_ **15.1 Cost or valuation**
|At beginning of the year
Additions
Disposals
Revaluations
Transfers *
At end of the year|**Research &**
**development**
**£**|**Patents and**
**trademarks**
**£**|**Other**
**£**|**Total**
**£**|
|---|---|---|---|---|
||-|-|-|-|
||-|-|-|-|
||-|-|-|-|
||-|-|-|-|
||-|-|-|-|
||-|-|-|-|
## **15.2 Amortisation and impairments**
|****Basis**
**** Rate**
At beginning of the year
Disposals
Amortisation
Impairment
Transfers*
At end of year
Net book value at the beginning
of the year
Net book value at the end of the
year
**15.3 Net book value**|SL or RB|SL or RB|SL or RB|SL or RB|Straight Line
("SL") or
Reducing
Balance
("RB")|
|---|---|---|---|---|---|
|||||||
||- - - -
- - - -
- - - -
- - - -
- - - -
- - - -
- - - -
- - - -|||||
||-|-|-|-||
||-|-|-|-||
## **15.4 Accounting policy**
_**Please disclose the accounting policy for intangible fixed assets including: Reasons for choosing amortisation rates**_
_**Policies for the recognition of any capital development**_
## **15.5 Impairment**
## **This year:**
CC17a (Excel)
26/01/2023
26
|**Last year:**
**15.6 Revaluation**
**_Please provide a description of the events and_**
**_circumstances that led to the recognition or reversal of an_**
**_impairment loss._**
**15.7 Other disclosures**
**_(iii) Please provide the amount of contractual_**
**_commitments for the acquisition of intangible assets._**
**_If an accounting policy of revaluation is adopted, please provide:_**
**_the carrying amount that would have been recognised had_**
**_the assets been carried under the cost model._**
**_Please provide a description of the events and_**
**_circumstances that led to the recognition or reversal of an_**
**_impairment loss._**
**This year**
**Last year**
**_the effective date of the revaluation_**
**_(iv) State the amount of research and development_**
**_expenditure recognised as expenditure in the year._**
**_(v) Please detail the headings in the SOFA in which a_**
**_charge for amortisation of intangible assets is included._**
**_the name of independent valuer, if applicable_**
**_the methods applied_**
**_(vi) For any material intangible assets, please provide a_**
**_description, its carrying amount and any remaining_**
**_amortisation period._**
**_(i) If your intangible asset was acquired by way of grant,_**
**_provide value on initial recognition and carrying amount of_**
**_the asset._**
**_(ii) Details of the carrying amounts of any intangible_**
**_assets to which the charity has restricted title or that are_**
**_pledged as security for liabilities._**|||
|---|---|---|
||||
||||
||**This year**|**Last year**|
||||
||||
||||
||||
||||
||||
||||
||||
||||
||||
||||
- _`The "transfers" row is for movements between fixed asset categories.`_
```
** Please indicate the method of depreciation by deleting the method not applicable (SL = straight line; RB =
reducing balance). Also please indicate the rate of depreciation: for straight line, what is the anticipated life of
the asset (in years); for reducing balance, what is the percentage annual deduction.
```
CC17a (Excel)
26/01/2023
27
**Section C Notes to the accounts (cont)**
## **Note 16 Heritage assets**
## _**Please complete this note if the charity has heritage assets**_
## **16.1 General disclosures for all charities holding heritage assets**
|**(i) Explain the nature and scale of**
**heritage assets held.**
**(ii) Explain the policy for the**
**acquisition, preservation,**
**management and disposal of heritage**
**assets.**|**Thisyear**|**Lastyear**|
|---|---|---|
||||
||||
## **16.2 Cost or valuation**
|At beginning of the year
Additions
Disposals
Revaluations
Transfers *
At end of the year
****Basis**
**** Rate**
At beginning of the year
Disposals
Depreciation
Impairment
Transfers*
At end of year
Net book value at the beginning of the
year
Net book value at the end of the year
**16.3 Depreciation and impairments**
**16.4 Net book value**|**Heritage asset**
**1**
**£**|
**Heritage asset**
**2**
**£**|
**Heritage asset**
**3**
**£**|
**Heritage asset**
**4**
**£**|
**Total**
**£**|
**Total**
**£**|
|---|---|---|---|---|---|---|
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
|||||||Straight Line
("SL") or
Reducing
Balance
|
|||||||("RB")|
||- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -||||||
||-|-|-|-|-||
||-|-|-|-|-||
## **16.5 Impairment**
CC17a (Excel)
26/01/2023
28
## **This year**
_**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_
**Last year** _**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_
## **16.6 Revaluation**
_**If an accounting policy of revaluation is adopted, please provide:**_
_**the effective date of the revaluation the name of independent valuer, if applicable qualifications of independent valuer the methods applied and significant assumptions any significant limitations on the valuation**_
**This year Last year**
## **16.7 Analysis of heritage assets by class or group distinguishing those at cost and those at valuation**
|Carrying amount at the beginning of the
period
Additions
Disposals
Depreciation/impairment
Revaluation
Carrying amount at the end of period|**At valuation**
**Group A**
**£**|**At cost Group**
**B**
**£**|**Total**
**£**|
|---|---|---|---|
||-|-|-|
||-|-|-|
||-|-|-|
||-|-|-|
||-|-|-|
||-|-|-|
## **16.8 Heritage assets (where heritage assets are not recoignised on the balance sheet)**
**This year Last year (i) Explain the reason why heritage assets have not been recognised on the balance sheet. (ii) Describe the significance and nature of heritage assets.**
**(iii) Disclose information that is helpful in assessing the value of heritage assets.**
CC17a (Excel)
26/01/2023
29
## **(iv) Explain the reason why it is not practicable to obtain a valuation of heritage assets.**
## **16.9 Five year summary of heritage assets transactions**
||**2022**|**2021**|**2020**|**2019**|**2018**|
|---|---|---|---|---|---|
||**£**|**£**|**£**|**£**|**£**|
|**Purchases**
Group A
Group B
Group C
Other
**Donations**
Group A
Group B
Group C
Other
**Total additions**
**Charge for impairment**
Group A
Group B
Group C
Other
**Total charge for impairment**
**Disposals**
Group A - carrying amount
Group B - carrying amount
Group C
Other
**Total disposals**||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|||||
||-|||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
CC17a (Excel)
26/01/2023
30
**Section C Notes to the accounts (cont)**
## **Note 17 Investment assets**
_**Please complete this note if the charity has any investment assets.**_
## **17.1 Fixed assets investments (please provide for each class of investment)**
|Carrying (fair) value at beginning of
period
**Add:**additions to investments during
period*
**Less:**disposals at carrying value
**Less: impairments**
**Add: Reversal of impairments**
**Add/(deduct):**transfer in/(out) in the
period
**Add/(deduct):**net gain/(loss) on
revaluation
Carrying (fair) value at end of year|**Cash & cash**
**equivalents**|
**Listed**
**investments**|**Investment**
**properties**|**Social**
**investments**|**Other**|**Total**|
|---|---|---|---|---|---|---|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
***Please specify additions resulting from acquisitions through business combinations, if any.**
_**Please note that Fair Value in this context is the amount for which an asset could be exchanged between knowlegable and willing parties in an arm's length transaction. For traded securities, the fair value is the value of the security quoted on the London Stock Exchange Daily Official List or equivalent. For other assets where there is no market price on a traded market, it is the trustees' or valuers' best estimate of fair value.**_
**17.2 Please provide a breakdown of investments shown above agreeing with the balance sheet row B04 differentiating between those held at fair value and those held at cost less impairment.**
## **This year: Analysis of investments**
**Cash or cash equivalents Listed investments Investment properties Social investments Other investments**
**Total**
**Grand total (Fair value at year end+Cost less impairment)**
||||
|---|---|---|
|**Fair value at year end**|**Cost less impairment**||
|**£**|**£**||
|-|-||
|-|-||
|-|-||
|-|-||
|-|-||
|-|-||
|-|||
**Last year: Analysis of investments**
**Cash or cash equivalents Listed investments Investment properties Social investments Other investments**
**Total**
**Grand total (Fair value at year end+Cost less impairment)**
|||
|---|---|
|**Fair value at year end**|**Cost less impairment**|
|**£**|**£**|
|-|-|
|-|-|
|-|-|
|-|-|
|-|-|
|-|-|
|-||
CC17a (Excel)
26/01/2023
31
## **17.3 If your charity holds investment properties, please complete the following note:**
|**(i) Explain the methods and significant assumptions in**
**determining the fair value of investment property held by the**
**charity**
**(ii) Name or independent valuer, if applicable, and relevant**
**qualifications**
**(iii) Provide details of any restrictions on the ability to**
**realise investment property or on the remittance of income or**
**disposal proceeds**
**(iv) Explain any contractual obligations for the purchase,**
**construction or development of investment property or for**
**repairs, maintenance or enhancements**|**Thisyear**|**Lastyear**|
|---|---|---|
||||
||||
||||
||||
## **17.4 Please provide a breakdown of current asset investments, if applicable, agreeing with the balance sheet.**
|**Analysis of current asset investments**|**This year**|**Last year**|**Last year**||||
|---|---|---|---|---|---|---|
||**£**|**£**|||||
|**Cash or cash equivalents**|-|||-|||
|**Listed investments**|-|||-|||
|**Investment properties**|-|||-|||
|**Social investments**|-|||-|||
|**Other investments**|-|||-|||
|**Total**|-|||-|||
|**17.5 Guarantees**|||||||
||**Thisyear**||||**Lastyear**||
|**Please provide details and amount of any guarantee made to**|||||||
|**or on behalf of a third party**|||||||
|**Name of the entity or entities benefitting from those**|||||||
|**guarantees**|||||||
|**Please explain how the guarantee furthers the charity's aims**|||||||
|**17.5 Guarantees**
**Total**
**Analysis of current asset investments**
**Cash or cash equivalents**
**Listed investments**
**Investment properties**
**Social investments**
**Other investments**|**17.5 Guarantees**
**Total**
**Analysis of current asset investments**
**Cash or cash equivalents**
**Listed investments**
**Investment properties**
**Social investments**
**Other investments**|**This year**|**Last year**|**Last year**|**Last year**|
|---|---|---|---|---|---|
|||**£**|**£**|||
|||-|-|||
|||-|-|||
|||-|-|||
|||-|-|||
|||-|-|||
|||-|-|||
|**Please provide details and amount of any guarantee made to**
**or on behalf of a third party**
**Name of the entity or entities benefitting from those**
**guarantees**
**Please explain how the guarantee furthers the charity's aims**||**Thisyear**||**Lastyear**||
|||||||
|||||||
|||||||
|**17.6 Concessionary loans**
**Amount of concessionary loans made (****_Multiple_**
**_loans made may be disclosed in aggregate provided_**
**_that such aggregation does not obsure significant_**
**_information_ ).**
**Amount of concessionary loans received**
**_(Multiple loans received may be disclosed in_**
**_aggregate provided that such aggregation does not_**
**_obsure significant information)._**||||||
|||||**This year £**
**Last year £**
- -
- -
- -
- -
- -
**This year £**
**Last year £**
- -
- -
- -
- -
**Last year**||
|||**_Description_**||**This year £**|**Last year £**|
|||||-|-|
|||||-|-|
|||||-|-|
|||||-|-|
||**_Total_**|||-|-|
|||||||
|||**_Description_**||**This year £**|**Last year £**|
|||||-|-|
|||||-|-|
|||||-|-|
||**_Total_**|||-|-|
|||||||
|||**This year**||**Last year**||
CC17a (Excel)
26/01/2023
32
|**Where a charity has provided financial assets as**
**a form of security, the carrying amount of the**
**financial asset pledged as security and the terms**
**and conditions relating to its pledge.**
**For all investments measured at fair value, the**
**basis for determining the value, including any**
**assumptions applied when using a valuation**
**technique.**
**17.7 Additional information**
**Please provide information about the**
**significance of investments to the charity's**
**financial position or performance eg. terms and**
**conditions of loans or the use of hedging to**
**manage financial risk.**
**Amounts receivable after more than 1 year**
**Amounts payable after more than 1 year**
**Amounts receivable within 1 year**
**Terms and conditions eg interest rate, security**
**provided**
**Value of any concessionary loans which have**
**been committed but not taken up at the reporting**
**date**
**Amounts payable within 1 year**|||
|---|---|---|
||||
||||
||||
||||
||||
||||
||**Thisyear**|**Lastyear**|
||||
||||
||||
CC17a (Excel)
26/01/2023
33
**Section C Notes to the accounts (cont)**
## **Note 18 Stocks**
## _**Please complete this note if the charity holds any stock items**_
## **18.1 Please state the carrying amount of stock and work in progress analysed between activities.**
|**activities.**||||||
|---|---|---|---|---|---|
|**Charitable activities:**
**_Opening_**
**_Added in period_**
**_Expensed in period_**
**_Impaired_**
**_Closing_**
**Other trading activities:**
**_Opening_**
**_Added in period_**
**_Expensed in period_**
**_Impaired_**
**_Closing_**
**Other:**
**_Opening_**
**_Added in period_**
**_Expensed in period_**
**_Impaired_**
**_Closing_**
**Total this year**
**_Total previous year_**|**Stock**||**Donated goods**||**Work in**
**progress**|
||**For**
**distribution**|**For resale**|**For**
**distribution**|**For resale**||
||**£**|**£**|**£**|**£**|**£**|
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
||-|-|-|-|-|
||-|-|-|-|-|
**18.2 Please specify the carrying amount of any stocks pledged as security for liabilities**
|**This year**|**Last year**|
|---|---|
|**£**|**£**|
|||
CC17a (Excel)
26/01/2023
34
## **Section C Notes to the accounts (cont)**
## **Note 19 Debtors and prepayments**
_**Please complete this note if the charity has any debtors or prepayments.**_
|**_Please complete this note if the charity has any_**
**_debtors or prepayments._**|||
|---|---|---|
|**19.1 Analysis of debtors**
**Trade debtors**
**Prepayments and accrued income**
**Other debtors**|**This year**
**£**|**Last year**
**£**|
||-|-|
||-|-|
||49,305|15,120|
||49,305|15,120|
**Total**
## _**Please complete 19.2 where a material debtor is recoverable more than a year after the reporting date.**_
## **19.2 Analysis of debtors recoverable in more than 1 year (included in debtors above)**
|**Prepayments and accrued income**
**Other debtors**
**Total**
**Trade debtors**|**This year**
**£**|**Last year**
**£**|
|---|---|---|
||-|-|
||-|-|
||-|-|
||-|-|
||-|-|
CC17a (Excel)
26/01/2023
35
## **Section C Notes to the accounts (cont)**
## **Note 20 Creditors and accruals**
## _**Please complete this note if the charity has any creditors or accruals.**_
## **20.1 Analysis of creditors**
|**Accruals for grants payable**
**Bank loans and overdrafts**
**Trade creditors**
**Payments received on account for contracts or**
**performance-related grants**
**Accruals and deferred income**
**Taxation and social security**
**Other creditors**
**Total**|**Amounts falling due within**
**oneyear**|**Amounts falling due within**
**oneyear**|
**Amounts falling due after**
**more than oneyear**|
**Amounts falling due after**
**more than oneyear**|
|---|---|---|---|---|
||**This year**
**£**|**Last year**
**£**|**This year**
**£**|**Last year**
**£**|
||-|-|-|
-|
||-|-|-|
-|
||-|-|600|-|
||-|-|-|
-|
||631|-|600|-|
||-|-|-|
-|
||5|-|5|-|
||636|-|1,205|-|
## **20.2 Deferred income**
## _**Please complete this note if the charity has deferred income.**_
_**Please explain the reasons why income is deferred.**_
**This year Last year**
|**_Movement in deferred income account_**
**Balance at the start of the reporting period**
**Amounts added in current period**
**Amounts released to income from previous periods**
**Balance at the end of the reporting period**|**This year**
**£**|**Last year**
**£**|
|---|---|---|
||-|
-|
||-|
-|
||-|
-|
||-|
-|
CC17a (Excel)
26/01/2023
36
## **Section C Notes to the accounts (cont)**
## **Note 21 Provisions for liabilities and charges**
_**Please complete this note if you have included in charity expenditure any provisions. A provision is made when the charity has a liability of uncertain timing or amount.**_
## **21.1 Movements in recognised provisions and funding commitment during the period**
|**21.2 Please provide:**
**- a brief description of any obligations on the balance**
**sheet and the expected amount and timing of**
**resulting payments;**
**- an indication of the uncertainties about the amount**
**or timing of those outflows; and**
**- the amount of any expected reimbursement, stating**
**the amount of any asset that has been recognised for**
**that expected reimbursement.**
**21.3 For any funding commitment that is not**
**recognised as a liability or provision, provide details**
**of commitment made, the time frame of that**
**commitment, any performance-related conditions and**
**details of how the commitment will be funded (with**
**contracts for capital expenditure separately**
**identified).**
**21.4 Where unrestricted funds have been designated**
**to a fund commitment, please disclose the nature of**
**any amounts designated and the likely timing of that**
**expenditure.**
**Balance at the end of the reporting period**
**Amounts added in current period**
**Amounts charged against the provision in the current**
**Unused amounts reversed during the period**
**Balance at the start of the reporting period**|**Thisyear**
**period**|**This year**
**£**|**Last year**
**£**|
|---|---|---|---|
|||-|-|
|||-|-|
|||-|-|
|||-|-|
|||-|-|
|||**Lastyear**||
|||||
|||||
|||||
||**Thisyear**|**Lastyear**||
|||||
|||||
|||||
CC17a (Excel)
26/01/2023
37
**Section C Notes to the accounts (cont)**
## **Note 22 Other disclosures for debtors, creditors and other basic financial instruments**
**This year Last year 22.1 Please provide information about the significance of financial instruments (eg. debtors, creditors, investments etc) to the charity's financial position or performance, for example, the terms and conditions of loans or the use of hedging to manage financial risk. 22.2 If the charity has provided financial assets as a form of security, the carrying amount of the financial assets pledged as security and the terms and conitions related to its pledge should be given here.**
CC17a (Excel)
26/01/2023
38
**Section C Notes to the accounts (cont)**
## **Note 23 Contingent liabilities and contingent assets**
## **23.1 Contingent liabilities**
**Where the charity has contingent liabililities, please complete the following section unless the possibility of their existence is remote.**
## **This year**
|**This year**||
|---|---|
|**Description of item including its legal nature. Please**
**describe any security provided in connection to the**
**liability.**|**Estimate of financial effect**|
|||
|||
|||
|||
|**Lastyear**||
|**Description of item including its legal nature. Please**
**describe any security provided in connection to the**
**liability.**|**Estimate of financial effect**|
|||
|||
|||
|||
## **23.2 Contingent assets**
**Where the charity has contingent assets, please complete the following section when their existence is probable**
## **This year**
## **Last year**
**Description of item Estimate of financial effect Description of item Estimate of financial effect**
**23.4 Other disclosures for contingent assets and/or liabilities Please provide the following information where practicable:**
**This year Last year**
**Explain any uncertainties relating to the amount or timing of settlement; and the possibilty of any reimbursement**
**Where it is not practical to make one or more of these disclosures, please state this fact**
CC17a (Excel)
26/01/2023
39
## **Section C Notes to the accounts (cont)**
## **Note 24 Cash at bank and in hand**
|**Note 24 Cash at bank and in hand**|||
|---|---|---|
|**Other**
**Cash at bank and on hand**
**Total**
**Short term cash investments (less than 3 months maturity date)**
**Short term deposits**|**This year**
**£**|**Last year**
**£**|
||-|-|
||-|-|
||92,592|22,328|
||-|-|
||92,592|22,328|
CC17a (Excel)
26/01/2023
40
## **Section C Notes to the accounts (cont)**
## **Note 25 Fair value of assets and liabilities**
|**25.1 Please provide details of the charity's**
**exposure to credit risk (the risk of incurring a loss**
**due to a debtor not paying what is owed) , liquidity**
**risk (the risk of not being able to meet short term**
**financial demands) and market risk (the risk that**
**the value of an investment will fall due to changes**
**in the market) arising from financial instruments to**
**which the charity is exposed at the end of the**
**reporting period and explain how the charity**
**manages those risks.**
**25.2 Please give details of the amount of change in**
**the fair value of basic financial instruments**
**(debtors, creditors, investments (see section 11,**
**FRS 102 SORP)) measured at fair value through the**
**SoFA that is attributable to changes in credit risk.**|**Thisyear**
**Lastyear**|**Thisyear**
**Lastyear**|
|---|---|---|
||||
||||
||
||
CC17a (Excel)
26/01/2023
41
**Section C Notes to the accounts (cont)**
## **Note 26 Events after the end of the reporting period**
_**Please complete this note events (not requiring adjustment to the accounts) have occurred after the end of the reporting period but before the accounts are authorised which relate to conditions that arose after the end of the**_
|**Please provide details of the nature of the**
**event**
**Provide an estimate of the financial effect**
**of the event or a statement that such an**
**estimate cannot be made**|**Thisyear**
**Lastyear**|**Thisyear**
**Lastyear**|
|---|---|---|
||||
||||
||||
CC17a (Excel)
26/01/2023
42
|**Section C Notes to the accounts (cont)**
**Note 27 Charity funds**|**_Please give details of the movements of material individual funds in the reporting period together with a balancing figure for 'Other funds'. The 'Total funds' figure below_**
**_should reconcile to 'Total funds' in the blanace sheet._**
**_* Key: PE - permanent endowment funds; EE - expendible endowment funds; R - restricted income funds, including special trusts, of the charity; and U - unrestricted_**
**_funds_**
**27.1 Details of material funds held and movements during the CURRENT reporting period**|**Fund**
**balances**
**carried**
**forward**
**£**|141,261|-|-|-|-|-|-|-|-|-|-|141,261|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||**Gains and**
**losses**
**£**|-|-|-|-|-|-|-|-|-|-|-|-|
|||**Transfers**
**£**|-|-|-|-|-|-|-|-|-|-|-|-|
|||**Expenditure**
**£**|- 27,537|-|-|-|-|-|-|-|-|-|-|- 27,537|
|||**Income**
**£**|132,555|-|-|-|-|-|-|-|-|-|-|132,555|
|||**Fund**
**balances**
**brought**
**forward**
**£**|36,243|-|-|-|-|-|-|-|-|-|-|36,243|
|||**Purpose and Restrictions**|For charitable activities||||||||||**N/a**|**Total Funds**|
|||**Type PE, EE**
**R or UR ***|U||||||||||**N/a**||
|||**Fund names**|Other funds (balancing figure)||||||||||**_Other funds_**||
|**Section C Notes to the accounts (cont)**
**Note 27 Charity funds (cont)**|**27.2 Details of material funds held and movements during the PREVIOUS reporting period**
**_Please give details of the movements of material individual funds in the reporting period together with a balancing figure for 'Other funds'. The 'Total funds' figure below_**
**_should reconcile to 'Total funds' in the blanace sheet._**
**_* Key: PE - permanent endowment funds; EE - expendible endowment funds; R - restricted income funds, including special trusts, of the charity; and U - unrestricted_**
**_funds_**|**Fund**
**balances**
**carried**
**forward**
**£**|36,243|-|-|-|-|-|-|-|-|-|-|36,243|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||**Gains and**
**losses**
**£**|-|-|-|-|-|-|-|-|-|-|-|-|
|||**Transfers**
**£**|-|-|-|-|-|-|-|-|-|-|-|-|
|||**Expenditure**
**£**|- 10,076|-|-|-|-|-|-|-|-|-|-|- 10,076|
|||**Income**
**£**|62,514|-|-|-|-|-|-|-|-|-|-|62,514|
|||**Fund**
**balances**
**brought**
**forward**
**£**|- 16,195|-|-|-|-|-|-|-|-|-|-|- 16,195|
|||**Purpose and Restrictions**|For charitable activities||||||||||**N/a**|**Total Funds**|
|||**Type PE, EE**
**R or UR ***|U||||||||||**N/a**||
|||**Fund names**|Other funds (balancing figure)||||||||||**_Other funds_**||
## **Section C Notes to the accounts (cont)**
## **Note 27 Charity funds (cont)**
## **27.3 Transfers between funds**
## **This year**
|**Thisyear**|||
|---|---|---|
||**Reason for transfer and where endowment is converted to income,**
**legalpower for its conversion**|**Amount**|
|Between unrestricted and
restricted funds|||
|Between endowment and
restricted funds|||
|Between endowment and
unrestricted funds|||
||||
## **Last year**
||**Reason for transfer and where endowment is converted to income,**
**legal power for its conversion**|**Amount**|
|---|---|---|
|Between unrestricted and
restricted funds|||
|Between endowment and
restricted funds|||
|Between endowment and
unrestricted funds|||
||||
## **27.4 Designated funds**
## **This year**
**Planned use Purpose of the designation Amount**
## **Last year**
**Planned use Purpose of the designation Amount**
CC17a (Excel)
26/01/2023
45
## **Section C Notes to the accounts (cont)**
## **Note 28 Transactions with trustees and related parties**
_**If the charity has any transactions with related parties (other than the trustee expenses explained in guidance notes) details of such transactions should be provided in this note. If there are no transactions to report, please enter “True” in the box or "False" if there are transactions to report.**_
## **28.1 Trustee remuneration and benefits**
## **This year**
**None of the trustees have been paid any remuneration or received any other benefits from an employment with their charity or a related entity (True or False)**
**----- Start of picture text -----**
TRUE
**----- End of picture text -----**
_**In the period the charity has paid trustees remuneration and benefits. Please give the amount of, and legal authority for, any remuneration or other benefits paid to a trustee by the charity or any institution or company connected with it.**_
|**Name of trustee**|**Legal authority (eg**
**order, governing**
**document)**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|
|---|---|---|---|---|---|---|
|||**Remuneration**|**Pension**
**contribution**|**Redundancy**
**(including**
**loss of**
**office)/ex**
**gratia**|**Other**|**TOTAL**|
|||**£**|**£**|**£**|**£**|**£**|
|||-|-|-|-|**-**|
|||-|-|-|-|**-**|
|||-|-|-|-|**-**|
|||-|-|-|-|**-**|
_**Please give details of why remuneration or other employment benefits were paid.**_
_**Where an ex gratia payment has been made to a trustee, provide an explanation of the nature of the payment.**_
## **Last year**
**None of the trustees have been paid any remuneration or received any other benefits from an employment with their charity or a related entity (True or False)**
**TRUE**
_**In the period the charity has paid trustees remuneration and benefits. Please give the amount of, and legal authority for, any remuneration or other benefits paid to a trustee by the charity or any institution or company connected with it.**_
|**Name of trustee**|**Legal authority (eg**
**order, governing**
**document)**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|
|---|---|---|---|---|---|---|
|||**Remuneration**|**Pension**
**contribution**|**Redundancy**
**(including**
**loss of**
**office)/ex**
**gratia**|**Other**|**TOTAL**|
|||**£**|**£**||**£**|**£**|
|||-|-|-|-|**-**|
|||-|-|-|-|**-**|
|||-|-|-|-|**-**|
|||-|-|-|-|**-**|
|**_Where an ex gratia payment has been made to a trustee,_**
**_provide an explanation of the nature of the payment._**
**_Please give details of why remuneration or other_**
**_employment benefits were paid._**|||||||
||||||||
||||||||
## **28.2 Trustees' expenses**
CC17a (Excel)
26/01/2023
46
_**If the charity has paid trustees expenses for fulfilling their duties, details of such transactions should be provided in this note. If there are no transactions to report, please enter “True” in the box below. If there are transactions to report, please enter "False".**_
**No trustee expenses have been incurred (True or False)**
|**Type of expenses reimbursed**|**This year**|**Last year**|
|---|---|---|
||**£**|**£**|
|**Travel**|-|-|
|**Subsistence**|-|-|
|**Accommodation**|-|-|
|**Other (please specify):**|-|-|
||-|-|
|**TOTAL**|-|-
|
**Please provide the number of trustees reimbursed for expenses or who had expenses paid by the charity**
## **28.3 Transaction(s) with related parties**
_**Please give details of any transaction undertaken by (or on behalf of) the charity in which a related party has a material interest, including where funds have been held as agent for related parties. If there are no such transactions, please enter 'true' in the box provided.**_
## **This year**
**There have been no related party transactions in the reporting period (True or False)**
|**Name of the trustee**
**or related party**|**Relationship**
**to charity**|**Description of the**
**transaction(s)**|**Amount**|**Balance at**
**period end**|**Provision for bad**
**debts at period end**|**Amounts**
**written off**
**during**
**reporting**
**period**|
|---|---|---|---|---|---|---|
||||**£**|**£**|**£**|**£**|
||||||||
||||||||
||||||||
||||||||
_**In relation to the transactions above, please provide the terms and conditions, including any security and the nature of any payment (consideration) to be provided in settlement.**_
_**For any related party, please provide details of any guarantees given or received.**_
## **Last year**
**There have been no related party transactions in the reporting period (True or False)**
|**Name of the trustee**
**or related party**|**Relationship**
**to charity**|**Description of the**
**transaction(s)**|**Amount**|**Balance at**
**period end**|**Provision for bad**
**debts at period end**|**Amounts**
**written off**
**during**
**reporting**
**period**|
|---|---|---|---|---|---|---|
||||**£**|**£**|**£**|**£**|
||||||||
||||||||
||||||||
||||||||
_**In relation to the transactions above, please provide the terms and conditions, including any security and the nature of any payment (consideration) to be provided in settlement.**_
_**For any related party, please provide details of any guarantees given or received.**_
CC17a (Excel)
26/01/2023
47
**Section C Notes to the accounts (cont)**
## **Note 29 Additional Disclosures**
**The following are significant matters which are not covered in other notes and need to be included to provide a proper understanding of the accounts. If there is insufficient room here, please add a separate sheet.**
CC17a (Excel)
26/01/2023
48
(HARITY COMMISSION
FOR ENGLAND AND WALES
Independent examiner's report on the
accounts
Section A
Independent Examinerfs Report
Report to the trusteesl
members of
On accounts for the year
ended
31 March 2022
Charity no
(if any)
1171106
Set out on pages
1to48
We report to the trustees on my examination of the accounts of the above
tharity (Ihe Trust'l for the year ended
Responsibilities and
basis of report
As the charity's trustees, you are responsible for the preparation of the
accounts in accordance with the requirements of the Charities Ad 2011
{tthe Act").
We report in respect of my examination of the Trust's accounts carried out
under section 145 of the 2011 Act and in carying out our examination, we
have followed all the applicable Directions given by the Charity Commission
under section 145(5)(b) of the Act.
Independent We have completed our examination. We confirm that no material matters
examinerfs statement have come to our attention in connection with the examination {olher than
that disclosed below '} which gives us cause to believe that in. any material
respect:
the accounting records were not kept in accordan with section 130
of the Charities Act. or
the accounts did not accord wtth the accounting records., or
the accounts did not comply wtth the applicable requirements
conceming the fomi and content of accounts set out in the Charities
(Accounts and Reports} Regulations 2008 other than any requiremenl
that the accounts give a 'true and fairf view which is not a matter
considered as part of an independent examination.
We have no concems and have come across no other matters in
connection with the examination to which attention should be drawn in
this report in order to enable a proper understanding of the accounts to
be reached.
Signed:
Date:
31.ol. 3•13
Name:
Hines Haryey Woods Ltd
Relevant professional
qualification(s) or body
(if any):
Association of Chartered Certified Accountants ('ACCA°)
IER
Oct 2018
Address:
Queens Head Housa
The Street. Acle
Norwich. NR13 3DY
Section B
Disclosure
Only complete if the examiner needs to highlight material matters of concern
(see CC32, Independent examination of charity accounts.. directions and
guidance for examiners).
Glve hère brlef detalls of
any iterns that the
examinerwishos to
disclose.
IER
Oct 2018